Piermont Capital Management’s FibroGen FGEN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-200	Closed	-$231K	–	247
2018 Q1	$231K	Sell	200 -34	-15%	-$39.3K	0.08%	228
2017 Q4	$277K	Sell	234 -149	-39%	-$176K	0.09%	221
2017 Q3	$515K	Sell	383 -404	-51%	-$543K	0.17%	155
2017 Q2	$636K	Buy	+787	New	+$636K	0.18%	207